| 1 | negative regulation of phosphatidylinositol 3-kinase signaling (GO:0014067) | 6.67365583 |
| 2 | regulation of ruffle assembly (GO:1900027) | 6.41956138 |
| 3 | regulation of hydrogen peroxide metabolic process (GO:0010310) | 6.37032437 |
| 4 | dermatan sulfate metabolic process (GO:0030205) | 6.23336959 |
| 5 | positive regulation of protein kinase C signaling (GO:0090037) | 5.84078673 |
| 6 | chondroitin sulfate catabolic process (GO:0030207) | 5.57409337 |
| 7 | semaphorin-plexin signaling pathway (GO:0071526) | 5.55128335 |
| 8 | response to manganese ion (GO:0010042) | 5.28372368 |
| 9 | face development (GO:0060324) | 5.15572371 |
| 10 | negative regulation of cell size (GO:0045792) | 5.15096323 |
| 11 | quaternary ammonium group transport (GO:0015697) | 5.03683081 |
| 12 | insulin-like growth factor receptor signaling pathway (GO:0048009) | 4.94284979 |
| 13 | negative regulation of osteoblast proliferation (GO:0033689) | 4.88077475 |
| 14 | regulation of ARF GTPase activity (GO:0032312) | 4.76190145 |
| 15 | histone H3-K9 demethylation (GO:0033169) | 4.74244231 |
| 16 | response to magnesium ion (GO:0032026) | 4.70599046 |
| 17 | mannose metabolic process (GO:0006013) | 4.38237469 |
| 18 | ear development (GO:0043583) | 4.24433449 |
| 19 | endothelial cell chemotaxis (GO:0035767) | 4.19462842 |
| 20 | positive regulation of histone deacetylation (GO:0031065) | 4.17972430 |
| 21 | regulation of histone H3-K27 methylation (GO:0061085) | 4.14300693 |
| 22 | diacylglycerol metabolic process (GO:0046339) | 4.10733403 |
| 23 | vascular endothelial growth factor signaling pathway (GO:0038084) | 3.88791872 |
| 24 | facial nerve structural organization (GO:0021612) | 3.85040441 |
| 25 | peptidyl-tyrosine autophosphorylation (GO:0038083) | 3.84722706 |
| 26 | negative regulation of fibroblast growth factor receptor signaling pathway (GO:0040037) | 3.79916426 |
| 27 | atrioventricular valve morphogenesis (GO:0003181) | 3.74557833 |
| 28 | regulation of protein polyubiquitination (GO:1902914) | 3.71041769 |
| 29 | regulation of respiratory burst (GO:0060263) | 3.65990072 |
| 30 | CD4-positive or CD8-positive, alpha-beta T cell lineage commitment (GO:0043369) | 3.62569255 |
| 31 | Rho protein signal transduction (GO:0007266) | 3.53880134 |
| 32 | regulation of clathrin-mediated endocytosis (GO:2000369) | 3.52696687 |
| 33 | white fat cell differentiation (GO:0050872) | 3.50029904 |
| 34 | planar cell polarity pathway involved in neural tube closure (GO:0090179) | 3.46433078 |
| 35 | melanocyte differentiation (GO:0030318) | 3.36566051 |
| 36 | cellular response to vascular endothelial growth factor stimulus (GO:0035924) | 3.34341267 |
| 37 | actin filament bundle assembly (GO:0051017) | 3.30357412 |
| 38 | actin filament bundle organization (GO:0061572) | 3.30357412 |
| 39 | definitive hemopoiesis (GO:0060216) | 3.22740762 |
| 40 | positive regulation of transcription from RNA polymerase II promoter in response to stress (GO:00360 | 3.21135077 |
| 41 | 2-oxoglutarate metabolic process (GO:0006103) | 3.18970461 |
| 42 | phosphatidylinositol 3-kinase signaling (GO:0014065) | 3.17593101 |
| 43 | lytic vacuole organization (GO:0080171) | 3.16876032 |
| 44 | lysosome organization (GO:0007040) | 3.16876032 |
| 45 | negative regulation of epidermal growth factor-activated receptor activity (GO:0007175) | 3.16874653 |
| 46 | histone H4 deacetylation (GO:0070933) | 3.16283595 |
| 47 | regulation of platelet-derived growth factor receptor signaling pathway (GO:0010640) | 3.14922739 |
| 48 | positive regulation of protein deacetylation (GO:0090312) | 3.09952647 |
| 49 | regulation of establishment of planar polarity involved in neural tube closure (GO:0090178) | 3.08598662 |
| 50 | negative regulation of axon extension involved in axon guidance (GO:0048843) | 3.08316632 |
| 51 | interferon-gamma secretion (GO:0072643) | 3.08082893 |
| 52 | regulation of triglyceride catabolic process (GO:0010896) | 3.07930216 |
| 53 | histone H3 deacetylation (GO:0070932) | 3.06549397 |
| 54 | pigment cell differentiation (GO:0050931) | 3.05691325 |
| 55 | cranial nerve morphogenesis (GO:0021602) | 3.04541814 |
| 56 | regulation of protein kinase C signaling (GO:0090036) | 3.04095112 |
| 57 | sulfur compound catabolic process (GO:0044273) | 3.00508593 |
| 58 | dendritic cell chemotaxis (GO:0002407) | 2.99802573 |
| 59 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 2.99541033 |
| 60 | regulation of apoptotic cell clearance (GO:2000425) | 2.97752237 |
| 61 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 2.93705896 |
| 62 | regulation of histone deacetylation (GO:0031063) | 2.89175063 |
| 63 | regulation of Rho protein signal transduction (GO:0035023) | 2.88987401 |
| 64 | positive regulation of macroautophagy (GO:0016239) | 2.87909156 |
| 65 | negative regulation of transcription by competitive promoter binding (GO:0010944) | 2.87045550 |
| 66 | endocrine hormone secretion (GO:0060986) | 2.83442734 |
| 67 | phospholipid scrambling (GO:0017121) | 2.82251543 |
| 68 | melanosome localization (GO:0032400) | 2.79781296 |
| 69 | activation of JUN kinase activity (GO:0007257) | 2.77953111 |
| 70 | regulation of cell migration involved in sprouting angiogenesis (GO:0090049) | 2.76667031 |
| 71 | phosphatidylglycerol biosynthetic process (GO:0006655) | 2.75367875 |
| 72 | regulation of sequestering of triglyceride (GO:0010889) | 2.71386002 |
| 73 | pigment granule localization (GO:0051875) | 2.69269613 |
| 74 | cardiac right ventricle morphogenesis (GO:0003215) | 2.68790747 |
| 75 | urinary tract smooth muscle contraction (GO:0014848) | 2.68349600 |
| 76 | regulation of T cell cytokine production (GO:0002724) | 2.66073450 |
| 77 | glycerophospholipid catabolic process (GO:0046475) | 2.65013002 |
| 78 | histone H3-K4 trimethylation (GO:0080182) | 2.64748321 |
| 79 | cranial nerve structural organization (GO:0021604) | 2.64627136 |
| 80 | lymph vessel development (GO:0001945) | 2.64555185 |
| 81 | negative regulation of lipopolysaccharide-mediated signaling pathway (GO:0031665) | 2.64049722 |
| 82 | negative regulation of protein tyrosine kinase activity (GO:0061099) | 2.63588524 |
| 83 | cartilage development involved in endochondral bone morphogenesis (GO:0060351) | 2.59218902 |
| 84 | Rap protein signal transduction (GO:0032486) | 2.58828694 |
| 85 | COPI coating of Golgi vesicle (GO:0048205) | 2.57896745 |
| 86 | Golgi transport vesicle coating (GO:0048200) | 2.57896745 |
| 87 | phosphatidylethanolamine biosynthetic process (GO:0006646) | 2.57131411 |
| 88 | negative regulation of interleukin-2 production (GO:0032703) | 2.57026451 |
| 89 | regulation of synapse maturation (GO:0090128) | 2.55393204 |
| 90 | positive regulation of bone remodeling (GO:0046852) | 2.54880313 |
| 91 | positive regulation of bone resorption (GO:0045780) | 2.54880313 |
| 92 | cell migration in hindbrain (GO:0021535) | 2.54388161 |
| 93 | glomerular filtration (GO:0003094) | 2.54261937 |
| 94 | glycosaminoglycan catabolic process (GO:0006027) | 2.53362565 |
| 95 | activation of transmembrane receptor protein tyrosine kinase activity (GO:0007171) | 2.52507101 |
| 96 | cAMP biosynthetic process (GO:0006171) | 2.52395386 |
| 97 | regulation of interleukin-13 production (GO:0032656) | 2.50650367 |
| 98 | retrograde transport, endosome to Golgi (GO:0042147) | 2.49261491 |
| 99 | regulation of establishment or maintenance of cell polarity (GO:0032878) | 2.48856259 |
| 100 | protein heterotrimerization (GO:0070208) | 2.48633622 |
ATP8A2P1 
